CNER — Thrive Precision Health Share Price
Last trade - 00:00- $88.04m
- $116.07m
- $11.77m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.04 | ||
| EV to EBITDA | 23.88 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | 35.01% | ||
Financial Summary
| Year End 31st Dec | Unit | 2005 | 2006 | 2007 | 2008 | 2009 | 2010E | 2011E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 5.49 | 11.77 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Thrive Precision Health Inc, formerly China New Energy Group Company (China New Energy), is a vertically integrated natural gas company engaged in the development of natural gas distribution networks, and the distribution of natural gas to residential, and industrial and commercial customers in small and medium-sized cities in China. Its major business activities include development and construction of local gas distribution networks, transportation of natural gas from suppliers to its storage facilities in a given operational location, and operating and maintaining the gas distribution networks. The Company owns the exclusive rights to develop distribution networks to provide natural gas to industrial, commercial and domestic consumers in the cities of Dashiqiao, Nandaihe, Zhanhua and Wuyuan.
Directors
- Yangkan Chong CHM (57)
- Tak Shing Yu CFO
- Dunhong Shi COO (50)
- Mary Fellows DRC (44)
- Chunming Guo DRC (52)
- John Kuhns DRC (64)
- Tie Li DRC (63)
- Shadron Stastney DRC (46)
- Last Annual
- December 31st, 2009
- Last Interim
- September 30th, 2010
- Incorporated
- October 9th, 2007
- Public Since
- September 11th, 2003
- No. of Shareholders
- 97
- No. of Employees
- 130
- Sector
- Natural Gas Utilities
- Industry
- Utilities
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 7,342,523,492
- Address
- 20/F Center Plaza, TIANJIN, 300042
- Web
- http://www.cnegc.com
- Phone
- +86 3103961691
- Auditors
- Child , Van Wagoner & Bradshaw , PLLC
Similar to CNER
Canadian Manoir Industries
Pink Sheets on Nasdaq
Energtek
Pink Sheets on Nasdaq
Quality Industrial
Pink Sheets on Nasdaq
FAQ
As of Today at 19:05 UTC, shares in Thrive Precision Health are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in Thrive Precision Health last closed at $0.01 and the price had moved by -25.06% over the past 365 days. In terms of relative price strength the Thrive Precision Health share price has underperformed the S&P500 Index by -33.88% over the past year.
There is no consensus recommendation for this security.
Thrive Precision Health does not currently pay a dividend.
Thrive Precision Health does not currently pay a dividend.
Thrive Precision Health does not currently pay a dividend.
To buy shares in Thrive Precision Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in Thrive Precision Health had a market capitalisation of $88.04m.
Here are the trading details for Thrive Precision Health:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CNER
Based on an overall assessment of its quality, value and momentum Thrive Precision Health is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Thrive Precision Health. Over the past six months, its share price has underperformed the S&P500 Index by -57.81%.
As of the last closing price of $0.01, shares in Thrive Precision Health were trading -46.24% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Thrive Precision Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Thrive Precision Health's management team is headed by:
- Yangkan Chong - CHM
- Tak Shing Yu - CFO
- Dunhong Shi - COO
- Mary Fellows - DRC
- Chunming Guo - DRC
- John Kuhns - DRC
- Tie Li - DRC
- Shadron Stastney - DRC